CIK 0001712762
- Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465211056
- Phone
- +1 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-01 | DIAMOND STUART Director | Grant or award | +33,784 | 99,088 | ||
| 2024-06-12 | DIAMOND STUART Director | Grant or award | +8,296 | 65,304 | ||
| 2024-01-01 | DIAMOND STUART Director | Grant or award | +12,668 | $1.48 | $19K | 57,008 |
| 2023-10-01 | DIAMOND STUART Director | Grant or award | +11,867 | $1.58 | $19K | 44,340 |
| 2023-07-01 | DIAMOND STUART Director | Grant or award | +10,245 | $1.83 | $19K | 32,473 |
| 2023-04-15 | DIAMOND STUART Director | Grant or award | +9,920 | $1.89 | $19K | 22,228 |
| 2023-01-01 | DIAMOND STUART Director | Grant or award | +8,227 | $2.28 | $19K | 12,308 |
| 2022-08-31 | DIAMOND STUART Director | Purchase | +4,081 | 4,081 | ||
| 2022-08-31 | DIAMOND STUART Director | Purchase · Warrants (right to buy) | +4,081 | 4,081 | ||
| 2022-08-31 | DIAMOND STUART Director | Purchase · Non-tradeable Warrants (right to buy) | +4,081 | 4,081 |
Page 1 of 1 · 10 trades